CF
ABBV icon

Claris Financial’s AbbVie ABBV Stock Holding History

Claris Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.83M Buy
8,421
+581
+7% +$129K 1% 18
2025
Q4 		$1.79M Buy
7,840
+224
+3% +$51K 0.95% 18
2025
Q3 		$259K Buy
7,616
+2,140
+39% +$436K 0.15% 133
2025
Q2 		$1.02M Sell
5,476
-1,270
-19% -$236K 0.77% 33
2025
Q1 		$1.2M Hold
6,746
– – 0.79% 27
2024
Q4 		$1.2M Buy
+6,746
New +$1.24M 0.79% 27

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Claris Financial's ABBV Position: Q1 2026 in Review

Claris Financial increased its AbbVie (ABBV) stake by 7.4% in Q1 2026, buying an estimated $129K and bringing the position to 8,421 shares worth $1.83M. The position accounts for 1% of the portfolio, ranked #18.

Claris Financial first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Claris Financial held 8,421 shares of AbbVie worth $1.83M as of Q1 2026.
  • Claris Financial bought 581 AbbVie shares in Q1 2026, an estimated $129K.
  • AbbVie made up 1% of Claris Financial's portfolio in Q1 2026, its #18 holding.
  • Claris Financial first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Claris Financial's 13F filing for Q1 2026, filed 18 May 2026.